Mutlu, A. U. Et Al. 2023. Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone?. 13th International Gastrointestinal Cancers Conference, Antalya , (Antalya, Turkey), 1-66.

Mutlu, A. U., Adrejeni, M., Erdamar Çetin, A. S., & Ozer, L., (2023). Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone? . 13th International Gastrointestinal Cancers Conference, Antalya (pp.1-66). Antalya, Turkey

Mutlu, Arda Et Al. "Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone?," 13th International Gastrointestinal Cancers Conference, Antalya, Antalya, Turkey, 2023

Mutlu, Arda U. Et Al. "Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone?." 13th International Gastrointestinal Cancers Conference, Antalya , Antalya, Turkey, pp.1-66, 2023

Mutlu, A. U. Et Al. (2023) . "Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone?." 13th International Gastrointestinal Cancers Conference, Antalya , Antalya, Turkey, pp.1-66.

@conferencepaper{conferencepaper, author={Arda Ulaş Mutlu Et Al. }, title={Heterogenous Nature of the Microsatellite Status Should Be Considered In The Treatment of Gastric Cancer: Beware of Immunotherapy Alone?}, congress name={13th International Gastrointestinal Cancers Conference, Antalya}, city={Antalya}, country={Turkey}, year={2023}, pages={1-66} }